Biopharma teams
Integrate structure-resolved endpoints into translational, pharmacodynamic or biomarker-development studies.
COLLABORATE WITH USBuild the study around
Build the study around
a defined biological question.
Nebulum works with drug developers and research teams to align specimen collection, marker panels, volumetric imaging and structure-centric outputs with a pre-specified translational objective.
Start a study discussion ↗
01 / WHO WE WORK WITH
A shared platform for
translational teams.
The collaboration model begins with intended use—not a fixed panel or a generic report.
Clinical investigators
Test defined DNA-trap hypotheses in prospectively collected or well-annotated research cohorts.
Academic researchers
Apply volumetric whole-blood imaging to mechanistic questions that depend on morphology or spatial context.
02 / HOW A STUDY TAKES SHAPE
From research question
to a defined measurement plan.
We align the study design before samples are processed, with endpoints and interpretation boundaries specified in advance.
Define intended use
Indication, intervention and decision context.
Specify the cohort
Collection, timepoints, controls and sample logistics.
Configure readouts
Burden, morphology, localization and interactions.
Predefine outputs
Analysis plan, quality boundaries and reporting format.
START THE CONVERSATION
Email the scientific team ↗Tell us what decision the study needs to inform.
Share the indication, intervention, available specimens or proposed cohort, collection timepoints and primary biological question.
Please do not send patient-identifiable information. Research use only; not for diagnostic procedures.